Skip to main content
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. — Investor Relations & Filings

Ticker · DLB ISIN · US25659T1079 LEI · 549300X04FB2QPCJ5J24 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,701 across all filing types
Latest filing 2015-02-20 Director's Dealing
Country US United States of America
Listing US DLB

About Dolby Laboratories, Inc.

https://www.dolby.com/

Dolby Laboratories, Inc. specializes in creating audio, visual, and voice technologies designed to enhance entertainment and communications. Originally known for its audio noise reduction and encoding systems, the company develops and licenses a broad portfolio of technologies. Key offerings include Dolby Atmos for immersive sound and Dolby Vision for high-dynamic-range (HDR) imaging, which have become standards in content creation and playback. These technologies are integrated into a wide array of applications, including cinema, home entertainment, mobile devices, broadcast, music, and gaming, with the goal of transforming the science of sight and sound into more spectacular and immersive experiences for consumers.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2015-02-20 English
NONE
Major Shareholding Notification
2015-02-17 English
SC 13G/A
Major Shareholding Notification
2015-02-13 English
DOLBY LABORATORIES, INC.
Major Shareholding Notification
2015-02-12 English
FORM 4 SUBMISSION
Director's Dealing
2015-02-12 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from Dolby Laboratories, Inc. to the Securities and Exchange Commission (SEC) staff regarding comments on the company's Form 10-K annual report for the fiscal year ended September 26, 2014. The letter addresses specific SEC inquiries about business operations, revenue recognition, legal costs, and compliance with export controls and sanctions. It references the 10-K filing multiple times and discusses planned expansions of disclosures in the upcoming 10-K. The document is not the 10-K report itself but a correspondence related to it, providing clarifications and responses to regulatory comments. Given the length (15,000 characters) and detailed content, it is not a brief announcement or certification but a regulatory correspondence. This type of document fits best under Regulatory Filings (RNS), as it is a regulatory communication that does not constitute the full annual report or audit report but addresses regulatory staff comments on the 10-K filing.
2015-02-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.